SCHEMBL4040918

SCHEMBL4040918

COc1ccc2cc(NC(=O)c3ccccc3NCc3ccnc(OC(N)=O)c3)c(=O)oc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.46
RXFP1 Q9HBX9 1/20 0.46
MAOB P27338 5/20 0.44
RAB9A P51151 5/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ACHE P22303 1/20 0.44
KIT P10721 5/20 0.44
BRAF P15056 5/20 0.44
HDAC1 Q13547 1/20 0.44
MAOA P21397 2/20 0.44
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CA12 O43570 3/20 0.42
CA1 P00915 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4038213 0.93 NPC1 (0.49) NPC1RXFP1MAOBRAB9AALDH1A1
SCHEMBL4036529 0.89 HDAC1 (0.46) NPC1RXFP1MAOBRAB9AALDH1A1
SCHEMBL4033398 0.87 NPC1 (0.49) NPC1RXFP1MAOBRAB9AALDH1A1
SCHEMBL4038209 0.86 NPC1 (0.50) NPC1RXFP1MAOBRAB9AALDH1A1
SCHEMBL6542788 0.83 APP (0.49) NPC1RXFP1MAOBRAB9AALDH1A1
SCHEMBL4038457 0.82 NPC1 (0.49) NPC1RXFP1MAOBRAB9AALDH1A1
SCHEMBL4037715 0.81 NPC1 (0.49) NPC1RXFP1MAOBRAB9AALDH1A1
SCHEMBL4037276 0.80 KDR (0.43) NPC1RAB9AMAPTKITBRAF
SCHEMBL4038456 0.80 NPC1 (0.50) NPC1RXFP1MAOBRAB9AALDH1A1
SCHEMBL4034444 0.79 NPC1 (0.47) NPC1RXFP1MAOBRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392680-B1 SELECTIVE ANTHRANILAMIDE PYRIDINE AMIDES AS INHIBITORS OF VEGFR-2 AND VEGFR-3 BAYER SCHERING PHARMA AG (DE) 2009-07-22 EP disclosed